125 related articles for article (PubMed ID: 12559125)
1. The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal.
Rasmussen K; Vandergriff J
Neuropharmacology; 2003 Jan; 44(1):88-92. PubMed ID: 12559125
[TBL] [Abstract][Full Text] [Related]
2. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
[TBL] [Abstract][Full Text] [Related]
3. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Vandergriff J; Rasmussen K
Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862
[TBL] [Abstract][Full Text] [Related]
4. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
Rasmussen K; Hsu MA; Vandergriff J
Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
[TBL] [Abstract][Full Text] [Related]
7. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
Rasmussen K
Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
Hong M; Milne B; Jhamandas K
Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats.
Pineda J; Torrecilla M; MartÃn-Ruiz R; Ugedo L
Neuropharmacology; 1998 Jun; 37(6):759-67. PubMed ID: 9707290
[TBL] [Abstract][Full Text] [Related]
10. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
Rasmussen K; Martin H; Berger JE; Seager MA
Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
[TBL] [Abstract][Full Text] [Related]
11. Afferent effects on locus coeruleus in opiate withdrawal.
Rasmussen K
Prog Brain Res; 1991; 88():207-16. PubMed ID: 1839935
[TBL] [Abstract][Full Text] [Related]
12. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis.
Rasmussen K; Aghajanian GK
Brain Res; 1989 Dec; 505(2):346-50. PubMed ID: 2598056
[TBL] [Abstract][Full Text] [Related]
14. Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration.
Rasmussen K; Krystal JH; Aghajanian GK
Psychopharmacology (Berl); 1991; 105(4):508-12. PubMed ID: 1771218
[TBL] [Abstract][Full Text] [Related]
15. Local opiate withdrawal in locus coeruleus neurons in vitro.
Ivanov A; Aston-Jones G
J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
17. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats.
Krystal JH; Compere S; Nestler EJ; Rasmussen K
Physiol Behav; 1996; 59(4-5):863-6. PubMed ID: 8778878
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
[TBL] [Abstract][Full Text] [Related]
19. Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus.
Medrano MC; Mendiguren A; Pineda J
Psychopharmacology (Berl); 2015 Aug; 232(15):2795-809. PubMed ID: 25787747
[TBL] [Abstract][Full Text] [Related]
20. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
Sullivan ME; Hall SR; Milne B; Jhamandas K
Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
